Milrinone Versus Dobutamine in Critically Ill Patients

Clinical trial NCT03207165 · COMPLETED

Trial details

NCT number: NCT03207165
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Low Cardiac Output Syndrome Cardiogenic Shock Acute Coronary Syndrome Pulmonary Edema

Start date: 2017-08-30
Primary completion: 2020-06-12
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.